Mitsuru Toda

Dr. Mitsuru Toda

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Shawn R LockhartShawn R Lockhart
Shawn R Lockhart
MTMitsuru Toda
Mitsuru Toda
KBKaitlin Benedict
Kaitlin Benedict
DCDiego H. Caceres
Diego H. Caceres
ALAnastasia P. Litvintseva
Anastasia P. Litvintseva
Endemic fungi are thermally dimorphic fungi that have a limited geographic range and can cause both primary disease and opportunistic infections. The Americas are home to more genera of endemic fungi than anywhere else on earth. These include Coccidioides, Histoplasma, Blastomyces, Paracoccidioides, and Sporothrix. Endemic fungi are found across the Americas and the Caribbean, from Blastomyces gilchristi, which extends into the northeast corners of North America, to Histoplasma capsulatum, which occurs all the way down in the southern regions of South America and into the Caribbean Islands. Symptoms of endemic fungal infection, when present, mimic those of many other diseases and are often diagnosed only after initial treatment for a bacterial or viral disease has failed. Endemic fungi place a significant medical burden on the populations they affect, especially in immunocompromised individuals and in resource-limited settings. This review summarizes the ecology, geographical range, epidemiology, and disease forms of the endemic fungi found in the Americas. An emphasis is placed on new and proposed taxonomic changes, including the assignment of new species names in Histoplasma, Blastomyces, and Paracoccidioides.

26 June 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
MPMarie A de Perio
Marie A de Perio
KBKaitlin Benedict
Kaitlin Benedict
SWSamantha Williams
Samantha Williams
CNChristine Niemeier-Walsh
Christine Niemeier-Walsh
BGBrett J. Green
Brett J. Green
RNRandall J. Nett
Randall J. Nett
In areas where Histoplasma is endemic in the environment, occupations involving activities exposing workers to soil that contains bird or bat droppings may pose a risk for histoplasmosis. Occupational exposures are frequently implicated in histoplasmosis outbreaks. In this paper, we review the literature on occupationally acquired histoplasmosis. We describe the epidemiology, occupational risk factors, and prevention measures according to the hierarchy of controls.

2 June 2025 in JAMA Network Open
Verified
Journal Article
Open access
SWSamantha L. Williams
Samantha L. Williams
KBKaitlin Benedict
Kaitlin Benedict
BJBrendan R. Jackson
Brendan R. Jackson
MRMalavika Rajeev
Malavika Rajeev
GCGail Cooksey
Gail Cooksey
MTMitsuru Toda
Mitsuru Toda
Importance: Coccidioidomycosis is an underrecognized fungal infection that can cause serious illness and constitutes a considerable public health burden. The number of cases is likely substantially higher than the nationally reported total, as surveillance does not capture patients who do not seek medical care or who are undiagnosed or misdiagnosed. Coccidioidomycosis is not reportable in all states, and cases not reported to public health entities are likewise missed. A systematic estimate of coccidioidomycosis burden is needed to raise awareness and inform public health interventions and policy.Objective: To assess the annual burden of symptomatic coccidioidomycosis in the US.Design, Setting, and Participants: This cross-sectional study developed models incorporating coccidioidomycosis cases reported to the National Notifiable Diseases Surveillance System from January 1 to December 31, 2019, as model inputs. Multipliers from US public health surveillance accounted for factors including health care–seeking behavior, underdiagnosis, underreporting, and in-hospital mortality. Multiplier values were sourced from a combination of literature review and expert opinion. Regional estimates were generated using endemicity levels categorized as high (Arizona and California), low (Nevada, New Mexico, Texas, Utah, and Washington), or unknown (all other states and Washington, DC). Data were accrued from January 1, 2022, to July 1, 2024, and analyzed from October 1, 2022, to September 1, 2024.Exposure: Coccidioidomycosis reported to public health surveillance entities.Main Outcomes and Measures: Models estimated annual incident symptomatic coccidioidomycosis cases, hospitalizations, and deaths nationally and regionally in the US.Results: A nationwide total of 273 000 (95% credible interval [CrI], 206 000-360 000) incident symptomatic coccidioidomycosis cases were estimated in 2019. High-endemic states accounted for the highest burden (125 000 [95% CrI, 94 000-165 000] cases), followed by states of unknown endemicity (103 000 [95% CrI, 66 000-155 000] cases) and low-endemic states (46 000 [95% CrI, 31 000-65 000] cases). Nationally, models estimated 23 000 annual hospitalizations (95% CrI, 18 000-28 000) and 900 annual deaths (95% CrI, 700-1100) associated with coccidioidomycosis.Conclusions and Relevance: In this cross-sectional study, the estimated national burden of symptomatic coccidioidomycosis in 2019 was 10 to 18 times higher than the number of cases reported through national surveillance. Better awareness, diagnostic testing practices, and reporting are needed to improve patient outcomes and enhance our understanding of coccidioidomycosis epidemiology.

6 October 2023 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
DSDallas James Smith
Dallas James Smith
RFRebecca J Free
Rebecca J Free
GTGeorge R Thompson
George R Thompson
JBJohn W Baddley
John W Baddley
PPPeter G Pappas
Peter G Pappas
MTMitsuru Toda
Mitsuru Toda
Coccidioidomycosis, histoplasmosis, and blastomycosis are underrecognized and frequently misdiagnosed fungal infections that can clinically resemble bacterial and viral community-acquired pneumonia. This guidance is intended to help outpatient clinicians test for these fungal diseases in patients with community-acquired pneumonia to reduce misdiagnoses, unnecessary antibacterial use, and poor outcomes.

3 August 2023 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
DSDallas James Smith
Dallas James Smith
JGJeremy A.W. Gold
Jeremy A.W. Gold
KBKaitlin Benedict
Kaitlin Benedict
KWKaren Wu
Karen Wu
MLMeghan Lyman
Meghan Lyman
TCTom M. Chiller
Tom M. Chiller
Fungal infections can cause severe disease and death and impose a substantial economic burden on healthcare systems. Public health research requires a multidisciplinary approach and is essential to help save lives and prevent disability from fungal diseases. In this manuscript, we outline the main public health research priorities for fungal diseases, including the measurement of the fungal disease burden and distribution and the need for improved diagnostics, therapeutics, and vaccines. Characterizing the public health, economic, health system, and individual burden caused by fungal diseases can provide critical insights to promote better prevention and treatment. The development and validation of fungal diagnostic tests that are rapid, accurate, and cost-effective can improve testing practices. Understanding best practices for antifungal prophylaxis can optimize prevention in at-risk populations, while research on antifungal resistance can improve patient outcomes. Investment in vaccines may eliminate certain fungal diseases or lower incidence and mortality. Public health research priorities and approaches may vary by fungal pathogen.

31 May 2019 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
Nancy ChowNancy Chow
Nancy Chow
MTMitsuru Toda
Mitsuru Toda
APAudrey F Pennington
Audrey F Pennington
EAEnock Anassi
Enock Anassi
RARobert L. Atmar
Robert L. Atmar
KBKarlyn D Beer
Karlyn D Beer
Among a convenience sample of immunosuppressed residents in the Hurricane Harvey–affected area of Houston, Texas, 49% of residents engaged in cleanup activities in water-damaged and mold-contaminated homes.